SIM0278 injection

DRUG2 trials

Sponsors

Jiangsu Simcere Pharmaceutical Co., Ltd., Simcere Pharmaceutical Co., Ltd

Conditions

Atopic Dermatitis (AD)Lupus Nephritis

Phase 2

A Phase 2 Study to Evaluate the Efficacy, Safety of SIM0278 in Subjects With Moderate to Severe Atopic Dermatitis

Not yet recruitingNCT07175233

Jiangsu Simcere Pharmaceutical Co., Ltd.Atopic Dermatitis (AD)

Start: 2025-10-27End: 2027-08-20Target: 184Updated: 2025-09-23

A Multicenter Phase 2a Clinical Study to Evaluate SIM0278 in Subjects With Active Lupus Nephritis

Not yet recruitingNCT07393451

Simcere Pharmaceutical Co., LtdLupus Nephritis

Start: 2026-03-31End: 2028-08-31Target: 60Updated: 2026-02-06